Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF) announced that its subsidiary Rocket Doctor has extended its engagement with the EngageWell Network to expand physician-led virtual care for low-income, uninsured and underinsured adults across New York City. The renewed engagement follows the New York Health Foundation-funded “Virtual Pathway to Care” pilot, which connected more than 400 underserved New Yorkers to virtual urgent care, preventive health consultations, psychiatric evaluations and primary care navigation.
The extended agreement took effect on July 1, 2026 and is aligned with related grant-funded telehealth initiatives through October 31, 2029. Rocket Doctor will work toward billing Medicaid directly where eligible, while maintaining no-cost access for participating patients. The partnership also aligns with the partners’ CVS Health Foundation-supported Healthy Aging Program, which runs through October 31, 2029 and targets 750 mental health assessments, 750 cognitive assessments and 750 heart health consultations, all free to adults aged 60 and older.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announced that its wholly owned subsidiary Rocket Doctor Inc. has been selected from more than 330 applicants as one of Canada’s Top 100 AI & Tech Startups for ALL IN 2026, the country’s largest AI and advanced technologies event.
The digital health platform will showcase its AI-powered, physician-led virtual care solutions at ALL IN in Montréal on September 16–17, 2026. Rocket Doctor Inc. supports over 350 physicians and has enabled more than 750,000 patient visits across North America, focusing on rural, remote and underserved communities, and leveraging its Global Library of Medicine decision-support system and intelligent clinical workflows.
Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) announced that its wholly owned subsidiary, Rocket Doctor Inc., has joined the Alliance for Connected Care’s Telehealth Voters Pledge, a national coalition advocating for permanent Medicare telehealth legislation in the United States.
Co‑Founder and COO Harry Cherniak is scheduled to travel to Washington, D.C. on July 23, 2026 to join healthcare leaders, clinicians, patient advocates, and industry organizations in presenting the pledge to Members of Congress. The initiative seeks to replace temporary Medicare telehealth extensions with long-term policy, aiming to reduce uncertainty for patients and providers.
According to the company, Rocket Doctor’s platform has supported over 750,000 patient visits and empowered more than 350 physicians across Canada and the U.S., and is now in‑network with U.S. payers representing about 21 million covered lives in California, New York, and Maryland.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) announced that its wholly owned digital health platform Rocket Doctor has achieved SOC 2 Type I compliance following an independent audit. The certification validates controls for security, availability, confidentiality and privacy as the company expands its healthcare services across North America.
According to Rocket Doctor AI, the audit reviewed information security, access management, data privacy, incident response, business continuity, risk management, governance, and secure development/change management processes. The company has begun working toward SOC 2 Type II compliance to assess the ongoing operational effectiveness of these controls.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF) appointed Andrew Lau, CPA, CA as Chief Financial Officer effective July 6, 2026, following its U.S. expansion that increased access to over 21 million covered lives.
The company granted Lau, consultants and employees 263,250 stock options at $0.70 per share and 319,830 RSUs, with three- to five-year terms and vesting provisions.
Rocket Doctor AI (OTC:AIRDF) entered its first U.S. value-based primary care agreement with a California independent physician association. The model uses recurring per-member-per-month payments and supports about 30,000 covered members across 9 payers and 65 plans.
The deal expands in-network access to over 5 million patients and brings Rocket Doctor’s California coverage to roughly 8.2 million covered lives, with an initial one-year term starting June 1, 2026 and automatic annual renewals.
Rocket Doctor AI (OTC:AIRDF, CSE:AIDR) entered a 12-month, automatically renewing partnership with Mindstride to provide after-hours and overflow physician coverage starting June 15, 2026.
The program uses Rocket Doctor’s network of 350+ licensed physicians to expand evening, weekend and high-demand access for eligible Mindstride patients across Ontario, Alberta and British Columbia.
Rocket Doctor AI (OTC:AIRDF) launched the first activation of its national motorsports marketing partnership with Rick Ware Racing and FinTekk AP at the inaugural Anduril 250 NASCAR Cup Series race on Naval Base Coronado.
The 2026 campaign includes ~50 motorsports activations and 14 primary races, targeting more than 21 million covered lives across the U.S., including 8.2 million eligible patients in California.
Rocket Doctor AI (OTC:AIRDF) announced that subsidiary Treatment.com, with Rush River Research, secured confirmed Year 2 NIH funding for its AI-powered, culturally responsive family medical history tool.
The Small Business Innovation Research grant totals about US$2 million, with Treatment receiving over US$500,000 through May 31, 2027 to enhance its Global Library of Medicine and clinical AI tools.
Rocket Doctor AI (CSE:AIDR, OTC:AIRDF, Frankfurt:939) granted 47,013 stock options at $0.71 per share, expiring in three years, and 514,801 RSUs with one-to-three-year terms to consultants and employees. These equity awards follow existing compensation plans, include vesting conditions, and carry a four-month-plus-one-day hold period.
The company also extended digital marketing and investor awareness services from 45 Degrees and Investment Publishing until September 30, 2026, with no additional compensation payable for the extended term.